OncoImmune: Merck adds experimental COVID-19 therapy with OncoImmune deal
Merck & Co Inc has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in...Read More
Read full article »
OncoImmune is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer and autoimmune diseases.
Read more